Clinical Trials Logo

Pre-eclampsia clinical trials

View clinical trials related to Pre-eclampsia.

Filter by:
  • Recruiting  
  • « Prev · Page 20

NCT ID: NCT01255202 Recruiting - Clinical trials for Preeclampsia/Toxemia

The Prediction of Preeclampsia/Toxemia in Twin Pregnancy

Start date: September 2009
Phase: N/A
Study type: Observational

The purpose of this study is to finout whetere uterinae artery flow , PP13 and endogolin levels in the serum and kongo red in the urine can predict preeclamsia toxemia in twin pregnancies.

NCT ID: NCT00870428 Recruiting - Preeclampsia Clinical Trials

Predicitve Use of Spot Urine Protein/Creatinine Ratios in Preeclampsia

Start date: March 2009
Phase: N/A
Study type: Observational

The investigators intend to perform a large prospective study looking at the predictability of the random urine protein-to-creatinine ratio compared to the gold standard 24-hour urine protein collection. Furthermore, the investigators plan to investigate whether analysis of proteinuria at shorter time intervals (4 and 8 hours) within the overall 24-hour collection period is predictive of the 24-hour sample. Lastly, the investigators plan to determine whether a combination of the random test with a shorter collection interval is comparable to the 24-hour collection.

NCT ID: NCT00865683 Recruiting - Insulin Resistance Clinical Trials

DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study)

Start date: April 2009
Phase: Phase 1
Study type: Interventional

Women with excess adiposity while pregnant are more likely to develop gestational diabetes and high blood pressure during pregnancy than women of healthy weights. This may occur because overweight and obese pregnant women are less sensitive to insulin and have more inflammation than pregnant women of healthy weights. This study will examine the effect of a nutritional supplement, docosahexaenoic acid (DHA), on improving insulin sensitivity and lessening inflammation in overweight and obese pregnant women.

NCT ID: NCT00409253 Recruiting - Clinical trials for Hypertension During Pre-Eclampsia

Treatment of Severe Hypertension During Pre-Eclampsia: A Preliminary Equivalence Study Between Urapidil and Nicardipine

Start date: June 2007
Phase: Phase 3
Study type: Interventional

The aim of this study is to confirm that URAPIDIL is as efficient and as safe as NICARDIPINE to correct severe hypertension in pre-eclamptic patients. - efficacy endpoint : mean arterial blood pressure corrected to 105-125 mmHg after 120 min of study drug administration. - safety endpoints : clinical, biological and ultrasound observation for any side effect.All infants will be observed in the neonatology unit (during 48h).

NCT ID: NCT00262093 Recruiting - Pre-Eclampsia Clinical Trials

Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence

Start date: November 2005
Phase: N/A
Study type: Observational

The reason for having a higher incidence of preeclampsia in primiparas may involve angiogenesis imbalance in these patients.

NCT ID: NCT00215969 Recruiting - Pre-Eclampsia Clinical Trials

Prospective Study in Pregnant Women With Hypercoagulopathy

Start date: January 2004
Phase: N/A
Study type: Observational

Pre-eclampsia is one of the most common causes of maternal and fetal morbidity and mortality. The aim of this study is to identify pregnant women at risk for pre-eclampsia or other cardiovascular complications at a very early state of the disease, and thereby improve the current method of screening.

NCT ID: NCT00117546 Recruiting - Preeclampsia Clinical Trials

Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia

Start date: September 2005
Phase: Phase 4
Study type: Interventional

A history of preeclampsia is associated with a low plasma volume and higher sympathetic activity. Methyldopa will suppress sympathetic activity to normal values. In this study, the researchers will test that effect on the total cardiovascular balance.